India pharma growth expectations in 2024 highest globally: CPHI & PMEC India

12 November 2023 | News

Over 60% of the executives in India are ‘highly positive’ in outlook for 2024

Ahead of this month’s CPHI & PMEC India (28th- 30th November, 2023) – the largest pharma event in India – organisers confirm that India has highest confidence in outsourcing growth globally among its pharma professionals.

Building on the back of last month’s CPHI Annual Report, in which India was widely seen as a global winner, executives from India have offered up the most positive outlook for 2024 – with 61% ‘highly positive’ and a further 37% ‘moderately confident’. This result contrasts with a global average of just 37% ‘highly positive’ and 54% ‘moderate’ in all executives.

The event, which is at the heart of pharma in India, will draw over 48,000 executives from 120 countries, bringing together every facet of the supply chain. Their aim: to network, learn, and establish the essential partnership infrastructure required to fuel growth in 2024. 

CPHI & PMEC India will be held at the India Expo Centre (Greater Noida) in the New Delhi Capital Region with more than 1800 exhibitors coalescing in the subcontinent’s largest gathering of pharma executives. The event is widely seen as a key barometer of industry growth in the year ahead and the outlook from the show floor remains remarkedly positive.

The event runs as part of the India Pharma Week, which hosts the annual CEO Roundtable, the Indian Pharma Awards and the Women in Pharma Roundtable.

The Awards, now in its 10th edition, will honour excellence across 13 categories, highlighting the invaluable work of industry champions, stalwarts & visionaries from across the Indian pharma industry. The awards night will be held in the evening of 28th November 2023 at the Expo Centre.



× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account